SIT INVESTMENT ASSOCIATES INC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 133 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
SIT INVESTMENT ASSOCIATES INC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,678
-13.5%
43,925
-18.3%
0.05%
-9.8%
Q2 2023$1,940
-5.6%
53,7750.0%0.05%
-8.9%
Q1 2023$2,054
-32.9%
53,7750.0%0.06%
-34.9%
Q4 2022$3,060
-99.9%
53,7750.0%0.09%
+34.4%
Q3 2022$2,126,000
+16.6%
53,775
+29.8%
0.06%
+16.4%
Q2 2022$1,823,000
+10.4%
41,4250.0%0.06%
+25.0%
Q1 2022$1,652,000
-0.8%
41,4250.0%0.04%
+12.8%
Q4 2021$1,666,000
+41.1%
41,425
-39.1%
0.04%
+34.5%
Q3 2017$1,181,000
+30.5%
68,000
-3.7%
0.03%
+31.8%
Q2 2017$905,000
-2.9%
70,600
-1.8%
0.02%
-4.3%
Q1 2017$932,000
+14.5%
71,900
-12.7%
0.02%
+9.5%
Q4 2016$814,000
-18.2%
82,3500.0%0.02%
-19.2%
Q3 2016$995,000
+39.9%
82,3500.0%0.03%
+36.8%
Q2 2016$711,000
-8.8%
82,3500.0%0.02%
+35.7%
Q1 2016$780,000
-45.3%
82,3500.0%0.01%
-48.1%
Q4 2015$1,427,000
+29.0%
82,3500.0%0.03%
+28.6%
Q3 2015$1,106,000
-40.5%
82,3500.0%0.02%
-38.2%
Q2 2015$1,859,000
+10.1%
82,350
-30.4%
0.03%
+17.2%
Q1 2015$1,689,000
+213.4%
118,250
+111.5%
0.03%
+222.2%
Q4 2014$539,00055,9000.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders